Excerpt:
The Food and Drug Administration (FDA) has approved the Paxman Scalp Cooling System which reduces the likelihood of chemotherapy-related hair loss for patients with solid tumors, such as ovarian, breast, colorectal and prostate cancers, according to a press release by Paxman, the United Kingdom-based manufacturer of the system.

https://www.curetoday.com/articles/f...r-solid-tumors